6-Sep-2025 New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients International Association for the Study of Lung Cancer Reports and Proceedings
6-Sep-2025 Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds International Association for the Study of Lung Cancer Reports and Proceedings
6-Sep-2025 COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC International Association for the Study of Lung Cancer Reports and Proceedings
6-Sep-2025 CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC International Association for the Study of Lung Cancer Reports and Proceedings
6-Sep-2025 Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital International Association for the Study of Lung Cancer Reports and Proceedings
5-Sep-2025 Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor Pennington Biomedical Research Center Business Announcement
5-Sep-2025 New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment Compuscript Ltd Peer-Reviewed Publication
5-Sep-2025 Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment Compuscript Ltd Peer-Reviewed Publication
5-Sep-2025 Natural medicines target tumor vascular microenvironment to inhibit cancer growth Compuscript Ltd Peer-Reviewed Publication
5-Sep-2025 Pioneering advances in in vivo CAR T cell production Compuscript Ltd Peer-Reviewed Publication